A multicentre, randomised, double blind, placebo-controlled, parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) device (Protexo®) in adults with poorly-controlled, severe allergic asthma: the LASER trial

Project Details

Description

Funded by the NIHR Health Technology Assessment programme
StatusFinished
Effective start/end date1/12/1331/05/17

Funding

  • Portsmouth Hospitals University NHS Trust: £15,499.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.